http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101951915-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
filingDate 2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd5fcdf37b88174ca6f28408ba91768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_214b2cb9242de34519d3a0322f094fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e8c0164a8083984e7565ec04010827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4aaaed32b90172f894f15b38855dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8920d306b7df3167ce60db901f8595c0
publicationDate 2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101951915-A
titleOfInvention Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and WNT signaling
abstract Synthetic oxysterols can be made and can be used for the treatment of bone disorders, obesity, cardiovascular disorders, and neurological disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507951-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111643733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104395331-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106232612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106232612-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104395331-A
priorityDate 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147787107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409108318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467315535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456636139

Total number of triples: 42.